- Home
- SMWB vs BIOA Comparison
SMWB vs BIOA Comparison
Compare SMWB & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SMWB | BIOA |
|---|---|---|
| Founded | 2007 | 2015 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 478.9M | 443.9M |
| IPO Year | 2021 | 2024 |
Fundamental Metrics
Financial Performance| Metric | SMWB | BIOA |
|---|---|---|
| Price | $5.75 | $18.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 3 |
| Target Price | ★ $14.38 | $13.50 |
| AVG Volume (30 Days) | 319.8K | ★ 929.4K |
| Earning Date | 02-10-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $275,429,000.00 | $5,917,000.00 |
| Revenue This Year | $16.89 | N/A |
| Revenue Next Year | $13.80 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 14.25 | N/A |
| 52 Week Low | $5.48 | $2.88 |
| 52 Week High | $17.64 | $24.00 |
Technical Indicators
Market Signals| Indicator | SMWB | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | 28.15 | 58.99 |
| Support Level | $5.48 | $19.06 |
| Resistance Level | $6.38 | $21.53 |
| Average True Range (ATR) | 0.31 | 2.18 |
| MACD | -0.11 | 0.06 |
| Stochastic Oscillator | 14.83 | 56.07 |
Price Performance
Historical ComparisonAbout SMWB Similarweb Ltd.
Similarweb Ltd provides digital data and analytics that power critical business decisions. The group recognizes revenue from subscriptions to the platform and other subscription products on a straight-line basis over the term of the contract subscription period beginning on the date access to the platform is granted, provided all other revenue recognition criteria have been met. It has geographic presence in Israel, the United States, the United Kingdom, Asia Pacific, Europe, and Other. The group generates the majority of its revenue from the United States.
About BIOA BioAge Labs Inc.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.